XPO1 inhibitor WJ01024 monotherapy or in combination with ruxolitinib in myelofibrosis
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Hu Zhou, Xuewen Song, Mengjuan Li, Bingjie Ding, Yirong Zhao, Baojie Ma, Lihui Qian, Yuli Xie
Institutions: Zhengzhou University, Henan Cancer Hospital
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417021486
Cites:
Cited by:
Related to: